Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases

Limited efficacy of current therapeutic approaches for neurodegenerative disease has led to increased interest in alternative therapies. Cord blood plasma (CBP) derived from human umbilical cord blood (hUCB) may be a potential therapeutic. Benefits of CBP injection into rodent models of aging or isc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrhart, Jared, Sanberg, Paul R., Garbuzova‐Davis, Svitlana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237605/
https://www.ncbi.nlm.nih.gov/pubmed/30334335
http://dx.doi.org/10.1111/jcmm.13898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237605/
https://www.ncbi.nlm.nih.gov/pubmed/30334335
http://dx.doi.org/10.1111/jcmm.13898

Ejemplares similares